Daily non-political popular news in brief.

New hope for patients with chronic lymphocytic leukemia

12-04-2006 · EurekAlert!

Patients treated with lenalidomide for relapsed chronic lymphocytic leukemia (CLL) or disease that no longer responds to chemotherapy have experienced a major response to therapy, according to a phase II study conducted by Asher Chanan-Khan, MD, Department of Medicine, Roswell Park Cancer Institute (RPCI). The results are published in the December 1 issue of the Journal of Clinical Oncology.

Keywords: hope, patients, chronic, lymphocytic, leukemia, patient

« Previous | Next »

Similar news on "New hope for patients with chronic lymphocytic leukemia":

First antisense drug provides benefit to subset of chronic lymphocytic leukemia patients
02-14-2007 · EurekAlert!
The first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients - those who are still sensitive to a chemotherapy drug often used to treat this cancer.
Similar news · Read more »
Complete response with oblimersen combination improves survival of CLL patients
12-09-2007 · EurekAlert!
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Similar news · Read more »
Mayo Clinic Cancer Center collaborating to find new tools to fight leukemia
12-10-2006 · EurekAlert!
Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide and rituximab, resulted in significant clinical response in patients with previously untreated chronic lymphocytic leukemia (CLL).
Similar news · Read more »
Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
Gene therapy protocol at UCSD activates immune system in patients with leukemia
02-11-2008 · EurekAlert!
A research team at the Moores Cancer Center at University of California, San Diego reports that patients with chronic lymphocytic leukemia who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells. The study will be published on line the week of Feb. 11-15 in the online edition of the Proceedings of the National Academy of Science.
Similar news · Read more »
Go team -- 2 kinds of teamwork improves care for chronic heart failure
02-02-2007 · EurekAlert!
Active patient involvement during treatment of chronic heart failure, coupled with partnership with healthcare team members to provide care consistent with evidence-based guidelines, dramatically improves quality of care for chronic heart failure patients according to a study by researchers from the Indiana University School of Medicine, the Regenstrief Institute and the Roudebush VA Medical Center.
Similar news · Read more »
Hepatitis B patients' understanding of infection and treatment deficient
05-24-2007 · EurekAlert!
Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem.
Similar news · Read more »
Gleevec, the targeted cancer pill, delivers more good news to patients
12-09-2007 · EurekAlert!
Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia.
Similar news · Read more »
5-year study shows Gleevec's potency against chronic myeloid leukemia
12-06-2006 · EurekAlert!
In a study of patients with chronic myeloid leukemia, some 95 percent have survived the cancer after five years due to treatment with Gleevec, according to results published this week in the New England Journal of Medicine. Howard Hughes Medical Institute investigator Brian Druker, who led the five-year study, said the findings demonstrate Gleevec's effectiveness against the formerly fatal disease.
Similar news · Read more »
New guidelines reinforce pulmonary rehab need for patients with COPD
05-07-2007 · EurekAlert!
New evidence-based guidelines from the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation recommend a comprehensive pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease, citing that pulmonary rehabilitation can help improve a patient's exercise tolerance, dyspnea and health-related quality of life, as well as decrease hospital stay and health-care utilization.
Similar news · Read more »